Articles related to CARDIAC SURGERY

The bRIGHT study demonstrates that T-TEER using the TriClip system can lead to sustained TR reduction and quality of life improvements in a diverse, real-world population with advanced tricuspid valve disease.

The P-WCD demonstrated a clinically significant cutaneous adverse device effect rate of only 2.30%, with no severe adverse events reported, suggesting a favorable safety profile for this novel wearable defibrillator.

Pulmonary thromboendarterectomy (PTE) offers significant symptom improvement for over 75% of CTEPH patients. Specialized care centers are critical for successful outcomes due to the complexity of the procedure.

Experience an in-depth exploration of heart failure management in Mont-Tremblant, Canada, where you’ll delve into the latest diagnostic and therapeutic advancements, gaining insights that are crucial for enhancing patient outcomes in your practice.

Johns Hopkins’ cardiac surgery team’s strategic expansion brings together globally recognized experts, enhancing our capabilities in treating complex heart conditions and advancing research in heart and lung transplantation.

In the complex landscape of post-cardiac surgery care, the incidence of new-onset PCSAF presents a significant challenge, necessitating a judicious approach to anticoagulation to prevent thromboembolic events while minimizing bleeding risks.